These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 10753731

  • 1. Randomized controlled trial of Mycobacterium vaccae immunotherapy in non-human immunodeficiency virus-infected ugandan adults with newly diagnosed pulmonary tuberculosis. The Uganda-Case Western Reserve University Research Collaboration.
    Johnson JL, Kamya RM, Okwera A, Loughlin AM, Nyole S, Hom DL, Wallis RS, Hirsch CS, Wolski K, Foulds J, Mugerwa RD, Ellner JJ.
    J Infect Dis; 2000 Apr; 181(4):1304-12. PubMed ID: 10753731
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Does immunotherapy with heat-killed Mycobacterium vaccae offer hope for the treatment of multi-drug-resistant pulmonary tuberculosis?
    Stanford JL, Stanford CA, Grange JM, Lan NN, Etemadi A.
    Respir Med; 2001 Jun; 95(6):444-7. PubMed ID: 11421500
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Immunotherapy with Mycobacterium vaccae in patients with newly diagnosed pulmonary tuberculosis: a randomised controlled trial. Durban Immunotherapy Trial Group.
    Lancet; 1999 Jul 10; 354(9173):116-9. PubMed ID: 10408487
    [Abstract] [Full Text] [Related]

  • 6. Safety and immunogenicity of a five-dose series of inactivated Mycobacterium vaccae vaccination for the prevention of HIV-associated tuberculosis.
    Waddell RD, Chintu C, Lein AD, Zumla A, Karagas MR, Baboo KS, Habbema JD, Tosteson AN, Morin P, Tvaroha S, Arbeit RD, Mwinga A, von Reyn CF.
    Clin Infect Dis; 2000 Jun 10; 30 Suppl 3():S309-15. PubMed ID: 10875806
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy.
    Jenkins PA, Campbell IA, Banks J, Gelder CM, Prescott RJ, Smith AP.
    Thorax; 2008 Jul 10; 63(7):627-34. PubMed ID: 18250184
    [Abstract] [Full Text] [Related]

  • 14. A randomized phase II study of SRL172 (Mycobacterium vaccae) combined with chemotherapy in patients with advanced inoperable non-small-cell lung cancer and mesothelioma.
    O'Brien ME, Saini A, Smith IE, Webb A, Gregory K, Mendes R, Ryan C, Priest K, Bromelow KV, Palmer RD, Tuckwell N, Kennard DA, Souberbielle BE.
    Br J Cancer; 2000 Oct 10; 83(7):853-7. PubMed ID: 10970684
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A randomised placebo controlled trial of delipidated, deglycolipidated Mycobacterium vaccae as immunotherapy for psoriatic arthritis.
    Dalbeth N, Yeoman S, Dockerty JL, Highton J, Robinson E, Tan PL, Herman D, McQueen FM.
    Ann Rheum Dis; 2004 Jun 10; 63(6):718-22. PubMed ID: 15140780
    [Abstract] [Full Text] [Related]

  • 17. Double-blind placebo-controlled trial of Mycobacterium vaccae immunotherapy for tuberculosis in KwaZulu, South Africa, 1991-97.
    Mayo RE, Stanford JL.
    Trans R Soc Trop Med Hyg; 2000 Jun 10; 94(5):563-8. PubMed ID: 11132390
    [Abstract] [Full Text] [Related]

  • 18. Immunological consequences of three doses of heat-killed Mycobacterium vaccae in the immunotherapy of tuberculosis.
    Dlugovitzky D, Fiorenza G, Farroni M, Bogue C, Stanford C, Stanford J.
    Respir Med; 2006 Jun 10; 100(6):1079-87. PubMed ID: 16278080
    [Abstract] [Full Text] [Related]

  • 19. Immunotherapy with Mycobacterium vaccae and the treatment of tuberculosis.
    Stanford JL, Stanford CA.
    Soc Appl Bacteriol Symp Ser; 1996 Jun 10; 25():81S-86S. PubMed ID: 8972123
    [No Abstract] [Full Text] [Related]

  • 20. Potential of Mw as a prophylactic vaccine against pulmonary tuberculosis.
    Katoch K, Singh P, Adhikari T, Benara SK, Singh HB, Chauhan DS, Sharma VD, Lavania M, Sachan AS, Katoch VM.
    Vaccine; 2008 Feb 26; 26(9):1228-34. PubMed ID: 18243430
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.